Insider · CIK 0001889476
AH Bio Fund IV, L.P.
Files at BRVE (Braveheart Bio, Inc.). First filing Aug 11, 2026, latest Aug 11, 2026.
In brief
AH Bio Fund IV, L.P. files SEC Form 4 as 10% owner at BRVE (Braveheart Bio, Inc.). Since Aug 11, 2026, AH Bio Fund IV, L.P. has reported 1 open-market buy worth $20M and 0 open-market sells worth $0, the latest filed on Aug 11, 2026.
A track record needs three past buys with six months of prices behind them; AH Bio Fund IV, L.P. has 0, so none is measured yet.
The newest scored trade: bought $20M of BRVE on Aug 7, 2026, filed Aug 11, 2026, scored 50 (moderate). In the last 12 months: 1 buy worth $20M and 0 sells worth $0.
Where the trades landed
Last year at the company this insider has traded most, with each buy and sell on the bar it happened.
BRVE: Braveheart Bio, Inc.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
This insider’s open-market buys and sells, scored.
| Score | Company | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 50Moderate | Braveheart Bio, Inc. | $20M 1,100,000 shares | +12% | - |
Transactions
Every row this insider has filed, 3 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Common Stockindirect: By AH Bio Fund IV, L.P. | +9,132,420 | - | - | 9,132,420 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | POpen-market purchase Common Stockindirect: By AH Bio Fund IV, L.P. | +1,100,000 | $18.00 | $20M | 10,232,420 | Aug 11, 2026 |
| Aug 7, 2026 | BRVE Braveheart Bio, Inc. | CConversion Series A Preferred Stockderivativeindirect: By AH Bio Fund IV, L.P. | -40,000,000 | $0.00 | $0 | 0 | Aug 11, 2026 |
Questions about AH Bio Fund IV, L.P.
Answered from the filings on this page, as of the latest one.
Is AH Bio Fund IV, L.P. buying or selling?
In the last 12 months AH Bio Fund IV, L.P. reported 1 open-market buy worth $20M and 0 open-market sells worth $0 on SEC Form 4; the latest was bought $20M of BRVE on Aug 7, 2026. Grants, option exercises and tax withholding are not counted.
How did AH Bio Fund IV, L.P.'s past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and AH Bio Fund IV, L.P. has 0.
Where does AH Bio Fund IV, L.P. file Form 4?
AH Bio Fund IV, L.P. has filed Form 4 at BRVE (Braveheart Bio, Inc.). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.